| Literature DB >> 35262777 |
Stefânia Prebianchi1, Eduardo Cezar Santos2, Adriana Dell'Aquila3, Carlos Finelli2, Fernando Baldy Reis2, Mauro José Salles3.
Abstract
PURPOSE: The issue of optimal prophylactic antibiotic administration for closed and open fracture surgeries remains controversial. The purpose of this study was to assess the role of type and duration longer than 48 h of antibiotic prophylaxis on the rates of fracture-related infection (FRI).Entities:
Keywords: Closed fractures; Duration; Fracture-related infection; Open fractures; Prophylactic antibiotic; Type of antibiotic
Year: 2022 PMID: 35262777 PMCID: PMC8905276 DOI: 10.1007/s00590-022-03246-7
Source DB: PubMed Journal: Eur J Orthop Surg Traumatol ISSN: 1633-8065
Demographic and fracture characteristics of the 132 patients evaluated
| Demographic, clinical, and surgical data | |
|---|---|
| Male—no. (%) | 99 (75.0) |
| Mean age in years (standard deviation) | 50.4 ± 22.9 |
| Smoking | 35 (26.5) |
| Alcoholism | 33 (25.0) |
| ASA& 1 | 97 (73.5) |
| ASA ≥ 2 | 35 (26.5) |
| Charlson index—no. (%) | |
| Up to 4 | 106 (80.9) |
| Over 4 | 25 (19.1) |
| Fall from standing height | 40 (30.3) |
| Road traffic accident | 56 (42.4) |
| Fall from height | 19 (14.4) |
| LL Fracture*—no. (%) | 106 (80.3) |
| Up to 12 h | 27 (20.5) |
| From 13 to 24 h | 24 (18.2) |
| From 25 to 72 h | 37 (28.0) |
| From 73 to 120 h | 18 (13.6) |
| From 121 to 240 h | 16 (12.1) |
| Over 240 h | 10 (7.6) |
| Open fracture | 36 (27.3) |
| I-II | 11 (30.6) |
| IIIA, IIIB, IIIC | 25 (69.4) |
| COVID-195 infection (no. {%}) | 5 (3.8) |
| Duration of antibiotic prophylaxis > 48 h no. (%) | 53 (40.2) |
| Prophylactic monotherapy | |
| Cephalosporin only | 104 (78.8) |
| Cephalosporin + aminoglycoside | 20 (15.1) |
| Others | 8 (6.1) |
#SAH: systemic arterial hypertension; 2ASA: American Society of Anesthesiologists preoperative classification; *LL: lower limbs; **GA: Gustilo–Anderson classification for open fractures; *** COVID-19: 2019 new coronavirus disease
Classes of antibiotic administered in antibiotic prophylaxis for open and closed fractures
| Antibiotic class/antibiotic | |
|---|---|
| Cephalosporin | 125 (94.7%) |
| Aminoglycoside | 21 (15.9%) |
| Glycopeptide | 4 (3.0%) |
| Quinolone | 4 (3.0%) |
| Carbapenem | 2 (1.5%) |
| Lincosamide | 2 (1.5%) |
| Oxazolidinone | 1 (0.8%) |
| Penicillin | 1 (0.8%) |
Summary of 21 patients with FRI
| Case | Sex | Age | ASA | Comorbidities/living habits | Type of fracture | Prophylaxis | Duration of therapy |
|---|---|---|---|---|---|---|---|
| 1 | M | 31 | 1 | Close | Cefazolin | > 48 h | |
| 2 | F | 77 | 3 | SAH; cancer | Close | Cefazolin | ≤ 48 h |
| 3 | M | 44 | 1 | Open | Meropenem + vancomycin | > 48 h | |
| 4 | M | 48 | 3 | SAH; DM; alcoholism | Close | Meropenem + linezolid + Amikacin | ≤ 48 h |
| 5 | M | 55 | 1 | Alcoholism; smoking | Open | Ceftriaxone | > 48 h |
| 6 | M | 65 | 2 | Cancer; smoking | Close | Cefazolin + gentamicin | > 48 h |
| 7 | M | 27 | 1 | Open | Cefazolin | > 48 h | |
| 8 | M | 34 | 1 | Smoking | Open | Cefazolin + gentamicin | > 48 h |
| 9 | M | 63 | 1 | Open | Cefazolin | ≤ 48 h | |
| 10 | F | 72 | 1 | SAH | Close | Cefazolin | > 48 h |
| 11 | M | 48 | 1 | Smoking | Open | Cefazolin + gentamicin | > 48 h |
| 12 | M | 44 | 2 | SAH | Close | Cefazolin + gentamicin | ≤ 48 h |
| 13 | F | 59 | 1 | Close | Cefazolin | ≤ 48 h | |
| 14 | F | 92 | 3 | DM; SAH | Close | Cefazolin | > 48 h |
| 15 | M | 30 | 1 | Smoking | Close | Ciprofloxacin + vancomycin | ≤ 48 h |
| 16 | M | 39 | 1 | Open | Cefalotin | > 48 h | |
| 17 | M | 18 | 1 | Open | Ciprofloxacin + clindamycin | ≤ 48 h | |
| 18 | M | 56 | 2 | DM; SAH | Open | Cefazolin + gentamicin | ≤ 48 h |
| 19 | F | 23 | 1 | Close | Ceftriaxone | > 48 h | |
| 20 | F | 73 | 2 | SAH | Open | Cefazolin | ≤ 48 h |
| 21 | M | 21 | 1 | Alcoholism | Open | Ceftriaxone | > 48 h |
ASA = American Society of Anesthesiologists; SAH = Systemic Arterial Hypertension; DM = Diabetes Mellitus/F/M = female/male